Non-Hodgkin's lymphoma (NHL) is the fifth most common cancer in the UK, with more than 10,700 people diagnosed with the disease every year. Professor Andrew Pettitt is carrying out a clinical trial, PACIFICO, to improve the treatment of older people with follicular lymphoma - the most common type of NHL.
The results could lead to a change in the way that these patients are treated in the future, helping to improve survival from the disease while minimising side effects.
